Why is Zim Laboratories falling/rising?

As of 24-Jun, Zim Laboratories Ltd is currently priced at 112.40, reflecting a decrease of 0.38, or 0.34%. The stock has recently underperformed its sector by 0.55% and has experienced a trend reversal, falling after three consecutive days of gains. Despite this, Zim Laboratories is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally positive trend in the short term. Over the past week, the stock has risen by 4.59%, and over the past month, it has increased by 24.75%. However, the company has faced challenges, including a 29.5% decline in profits over the past year, despite generating a return of 7.05%. This decline in profitability, coupled with poor long-term growth and negative results for the last four consecutive quarters, may be contributing to the stock's current downward movement.
In the broader market context, Zim Laboratories' short-term performance has significantly outpaced the Sensex, which has only increased by 0.58% over the past week. However, the stock's long-term performance remains concerning, with a 39.97% decline over the past three years compared to the Sensex's 55.62% increase during the same period. The lack of investment from domestic mutual funds, which hold 0% of the company, suggests a lack of confidence in the stock's future prospects, potentially influencing its current price movement. Overall, while there are some positive indicators such as rising investor participation and attractive valuation metrics, the negative financial performance and market sentiment appear to be weighing on the stock's price.